Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood

Blood

Volumn 90, Issue 8, 1997, Pages 3106-3117

  Qian, John X ^a   Lee, Sun Min ^a   Suen, Yu ^a   Knoppel, Eva ^a   Van De Ven, Carmella ^a   Cairo, Mitchell S ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 15; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0030879353     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.3106     Document Type: Article

References (75)

1. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NKC, McGlave PB, Sender L, Cairo MS: Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 88:795, 1996
2. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens C, Rubinstein P: Placental blood as a source of hemtopoietic stem cells for transplantation into unrelated recipients. N Eng J Med 335:157, 1996
3. Rosenthal J, Sweetman R, Sender S, Murphy L, Slone V, Cairo MS: Immunological reconstitution after unrelated cord blood (CB) transplantation. Pediatr Res 39:161A, 1996 (abstr)
4. Cairo M: Therapeutic implications of dysregulated colony-stimulating factor expression in neonates. Blood 82:2269, 1993
5. Monoz AI, Limbert D: Skin reactivity to Candida and streptokinase-streptodornase antigens in normal pediatric subjects: Influence of age and acute illness. J Pediatr 88:975, 1977
6. Franz ML, Carella JA, Galant SP: Cutaneous delayed hypersensitivity in a healthy pediatric population: Diagnostic value of diphtheria-tetanus toxoids. J Pediatr 88:978, 1976
7. - cell populations in cord blood and adult peripheral blood. J Immunol 135:2351, 1985
8. Baley JE, Schacter BZ: Mechanisms of diminished natural killer cell activity in pregnant women and neonates. J Immunol 134:3042, 1985
9. Miyawaki T, Moriya N, Nagaoki T, Taniguchi N: Maturation of B-cell differentiation ability and T-cell regulatory function in infancy and childhood. Immunol Rev 57:61, 1981
10. Palacios R, Andersson U: Autologous mixed lymphocyte reaction in human cord blood lymphocytes: Decreased generation of helper and cytotoxic T-cell functions and increased proliferative response and induction of suppressor T cells. Cell Immunol 66:88, 1982
11. Harris D, Schumacher M, Locascio J, Besencon F, Olson G, DeLuca D, Shenker L, Bard J, Boyse E: Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 89:10006, 1992
12. Harris DT, LoCascio J, Besencon FJ: Analysis of the alloreactive capacity of human umbilical cord blood: Implications for graft-versus-host disease. Bone Marrow Transplant 14:545, 1994
13. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE: Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 154:14, 1994
14. Risdon G, Gaddy J, Horie M, Broxmeyer HE: Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA 92:2413, 1995
15. Cairo M, Suen Y, Knoppel E, van de Ven C, Nguyen A, Sender L: Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared to adults. Pediatr Res 30:362, 1991
16. Cairo M, Suen Y, Knoppel E, Dana R, Park L, Clark S, van de Ven C, Sender L: Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborn infants. Pediatr Res 31:574, 1992
17. Suen Y, Lee S, Schreurs J, Knoppel E, Cairo MS: Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: Altered post transcriptional stability. Blood 84:4269, 1994
18. Lee SM, Suen Y, Chang L, Bruner V, Qian J, Indes J, Knoppel E, van de Ven C, Cairo MS: Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88:945, 1996
19. English K, Burchett S, English J, Ammann A, Wara D, Wilson C: Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Pediatr Res 24:717, 1988
20. Weatherstone K, Rich E: Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res 25:342, 1989
21. Wilson C, Westall J, Johnston L, Lewis D, Dower S, Alpert A: Decreased production of interferon-gamma by human neonatal cells. J Clin Invest 77:860, 1986
22. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson M, Watson JD, Anderson DM, Giri JG: Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965, 1994
23. Anderson DM, Johnson L, Glaccum M, Copelan NG, Gilbert DJ, Jenkins NA, Valentine V, Kirstein MN, Shapiro DN, Morriss SW, Grabstein K, Cosman D: Chromosomal assignment and genomic structure of IL-15. Genomics 25:701, 1995
24. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483, 1995
25. + hematopoietic progentior cells. Blood 87:2632, 1996
26. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4935, 1994
27. Bamford RN, Grant AJ, Burton JC, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4940, 1994
28. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395, 1994
29. Bamford RN, Battiata AP, Burton JD, Sharma H, Waldmann TA: Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc Natl Acad Sci USA 93:2897, 1996
30. c subunits. J Immunol 156:1339, 1996
31. Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, Callard R: Function of the interleukin-2 (IL-2) receptor γ-chain in biologic responses of x-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85:38, 1995
32. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytoine IL-15. J EMBO 13:2822, 1994
33. Munger W, DeJoy SQ, Jeyaseelan R Sr, Torley LW, Grabstein KH, Eisenmann J, Paxton R, Cox T, Wick MM, Kerwar SS: Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: Comparison with interleukin-2. Cell Immunol 165:289, 1995
34. Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY: Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 55:4988, 1995
35. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
36. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387, 1992
37. Biro S, Fu Y-M, Yu Z-X, Epstein S: Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 90:654, 1993
38. Lee S, Knoppel E, van de Ven C, Cairo M: Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3 and macrophage colony-stimulating factor genes in activated cord vs. adult mononuclear cells: Alteration in cytokine expression may be secondary to post-transcriptional instability. Pediatr Res 34:560, 1993
39. Weber B, Horiguchi J, Luebbers R, Sherman M, Kufe D: Posttranscriptional stabilization of c-fms mRNA by a labile protein during human monocytic differentiation. Mol Cell Biol 9:769, 1989
40. Groudine M, Peretz M, Weintraub H: Transcriptional regulation of hemoglobin switching in chicken embryos. Mol Cell Biol 1:281, 1981
41. 51CR-release assay for CTL-mediated target cell lysis, in Sitkovsky M, Henkart P (eds): Cytotoxic Cells, vol 43. Boston, MA, Birkhauser Boston, 1993, p 457
42. Pross HF, Baines MG, Rubin P, Shragge P, Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol 1:51, 1981
43. DeBlaker-Hohe DF, Yamauchi A, Yu C-R, Horvath-Arcidiacono JA, Bloom ET: IL-12 synergized with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 165:33, 1995
44. Sheridan W, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton J, Green M, Souza L, Fox R: Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891, 1989
45. Taylor K, Jagannath S, Spitzer G, Spinolo J, Tucker S, Fogel B, Cabanillas F, Hagemeister F, Souza L: Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 7:1791, 1989
46. Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ, Rifkin R, Rubin A, Agosti J, Hayes FA, Holcenberg J, Shadduck RK: Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant 15:949, 1995
47. Nemunaitis J, Rabinowe S, Singer J, Bierman P, Vose J, Freedman A, Onetto N, Gillis S, Oette D, Gold M, Buckner C, Hanson J, Ritz J, Appelbaum F, Armitage J, Nadler L: Recombinant granulocyute-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324:1773, 1991
48. Tepler I, Elias L, Smith JW, Hussein M, Rosen G, Chang AYC, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA: A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87:3607, 1996
49. Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewy J, Loesch D, Breeden E, Hoffman R, Beach KJ, Kuca B, Kaye J, Sledge GW: A phase I trial of recombinant human interleukin 11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87:3615, 1996
50. Basser RL, Rasko JEJ, Clarke K, Cebon J, Green MD, Hussein S, Alt C, Menchaca D, Tomita D, Marty J, Fox RM, Begley CG: Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 348:1279, 1996
51. Basser RL, Rasko J, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byre J, Menchaca DM, Fox RM, Begley CG: Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 89:3118, 1997
52. Vowels MR, Tiedemann K, Lam-Po-Tank R, Tucker DP: Use of granulocyte-macrophage colony-stimulating factor in two children treated with cord blood transplantation. Blood Cells 20:249, 1994
53. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA: Endogenous prodution of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 96:2578, 1995
54. Doherty TM, Seder RA, Sher A: Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156:735, 1996
55. Nishimura H, Hiromatsu K, Kobayashi N, Grabstein KH, Paxton R, Sugamura K, Bluestone JA, Yoshikai Y: IL-15 is a novel growth factor for murine γδ T cells induced by salmonella infection. J Immunol 156:663, 1996
56. Brawerman G: Finding the right targets. Cell 57:9, 1989
57. Brawerman G: Determinants of messenger RNA stability. Cell 48:5, 1987
58. Shaw G, Kamen R: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659, 1986
59. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shirmen S, Cerami A: Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670, 1986
60. Brewer G, Ross J: Poly (A) shortening and degradation of the 3′ A + U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol 8:1697, 1988
61. Malter J: Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664, 1989
62. Brewer G: An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol Cell Biol 11:2460, 1991
63. Wong G, Witek JS, Temple PA, Wilkkens KM, Leary AC, Luxemburg DP, Jones SS, Brown EL, Kay RM, Orr EC, Shoemaker C, Golde DW, Kaufman RJ, Hewick RM, Want EA, Clark SC: Human GM-CSF: Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228:810, 1985
64. Wong G, Temple P, Leary A, Witek-Gianotti J, Yang Y, Ciarletta A, Chung M, Murtha P, Kriz R, Kaufman R: Human CSF-1: Molecular cloning and expression of 4kb cDNA encoding the human urinary protein. Science 235:1504, 1987
65. Buzby JS, Lee SM, DeMaria CT, Brewer G, Van Winkle P, Cairo MS: Increased granulocyte-macrophage colony-stimulating factor mRNA instability in cord versus adult mononuclear cells is translation-dependent and associated with increased levels of A+U-rich element binding factor. Blood 88:2889, 1996
66. Jochum C, Voth R, Rossol S, Buschenfelde K, Hess G, Will H, Schroder H, Steffen R, Muller W: Immunosuppressive function of hepatitis B antigens in vitro: Role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J Virol 64:1956, 1990
67. Vakalopoulou E, Schaack J, Shenk T: A 32-kilodalton protein binds to All-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol Cell Biol 11:3355, 1991
68. Bohjanen P, Petryniak B, June C, Thompson C, Lindsten T: AU RNA-binding factors differ in their binding specificities and affinities. J Biol Chem 267:6302, 1992
69. Hamilton B, Nagy E, Malter J, Arrick B, Rigby W: Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem 268:8881, 1993
70. Levine T, Gao F, King P, Andrews L, Keene J: Hel-N1: An autoimmune RNA-binding protein with specficity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol 13:3494, 1993
71. Nakagawa J, Waldner H, Meyer-Monard S, Hofsteenge J, Jeno P, Moroni C: AUH, a gene encoding and AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc Natl Acad Sci USA 92:2051, 1995
72. Rosenberg S, Lotze M, Muul L: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485, 1985
73. Lee RE, Lotze MT, Skibber JM, Tucker E, Bonow RO, Ognibene FP, Carrasquillo JA, Shelhamer JH, Parrillo JE, Rosenberg SA: Cardiorespiratory effects of immunotherapy with interleukin-2. J Clin Oncol 7:7, 1989
74. Atkins MB, Robertson M, Gordon MS, Lotze MT, Du Bois J, Ritz J, Sandler A, Edington HD, Sherman ML: Phase I evaluation of intravenous recombinant human interleukin-12 (RHIL-12) in patients with advanced malignancies. Proc Am Soc Clin Oncol 15:270, 1996 (abstr)
75. Ross ME, Caligiuri MA: Cytokine-induced apoptosis of human natural killer (NK) cells identifies a novel mechanism to regulate the innate immune response. Blood 89:910, 1997